Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/1999
05/19/1999EP0915899A1 Preparation of crystal form ii of clarithromycin
05/19/1999EP0915898A1 Crystal form i of clarithromycin
05/19/1999EP0915857A1 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals
05/19/1999EP0915845A1 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
05/19/1999EP0915841A1 Anilinopeptide derivatives
05/19/1999EP0915823A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
05/19/1999EP0915707A1 Pharmaceutical composition comprising serum amyloid p component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components
05/19/1999EP0915705A1 Ionic polymers as anti-infective agents
05/19/1999EP0804456A4 Peptide nucleic acid conjugates
05/19/1999EP0654968B1 Anti-microbial composition
05/19/1999EP0633887B1 Calanolide antiviral compounds, compositions and uses thereof
05/19/1999EP0574466B1 Expression of recombinant proteins in attenuated bacteria
05/19/1999EP0552257B1 A plant protein useful for treating tumors and hiv infection
05/19/1999EP0434747B1 RECOMBINANT VACCINES BASED ON THE gB-PROTEIN OF MAREK'S DISEASE VIRUS
05/19/1999CN1217025A Processed polypeptides with IL-16 activity, process for preparing same and their use
05/19/1999CN1217024A Chemokine alpha 2
05/19/1999CN1216922A Porcine reproductive and respiratory syndrome vaccine
05/19/1999CN1216920A Acyl urea compounds for treatment of coccidioidomycosis in warmblooded animals
05/19/1999CN1216762A 2-(arylphenyl) amino-imidazoline derivatives
05/18/1999US5905082 Crystalline oxathiolane derivatives
05/18/1999US5905077 Inhibitors of HIV protease useful for the treatment of AIDS
05/18/1999US5905076 Treatment of muscular dystrophy, arthritis, myocardial infarction, alzheimer's disease, bacterial infection, common cold, osteoporosis or cancer metastasis
05/18/1999US5905070 5--Caboxamido or 5--fluoro!-- 2', 3'--unsaturated or 3'--modified!--pyrimidine nucleosides
05/18/1999US5905040 Eukaryotic transfectants express self-assembled empty viral capsids which can be used to vaccinate against the virus or antigenically related species of the virus.
05/18/1999US5904932 Topical preparation containing a suspension of solid lipid particles
05/18/1999US5904922 Purified chicken antivenom in aqueous solution
05/18/1999CA2140639C Iodine/resin disinfectant and a procedure for the preparation thereof
05/18/1999CA1340548C Method for producing native hiv gp160
05/18/1999CA1340543C Pharmaceutically active compounds
05/14/1999WO1999023212A1 Novel streptococcal ers
05/14/1999WO1999023082A1 AMINOTHIAZOLE DERIVATIVES USEFUL IN THE PREPARATION OF β-LACTAM ANTIBIOTICS
05/14/1999WO1999023076A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
05/14/1999WO1999022934A1 Prepolymer compositions comprising an antimicrobial agent
05/14/1999WO1999022763A2 Encapsulated immunomodulators useful as vaccine adjuvants
05/14/1999WO1999022761A1 Conjugate heat shock protein-binding peptides
05/14/1999WO1999022755A1 Use of granulysin as an antimicrobial agent
05/14/1999WO1999022742A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections
05/14/1999WO1999022734A1 Novel metal complexes
05/14/1999WO1999022733A1 Novel metal complexes
05/14/1999WO1999007839A3 Immunoprotective influenza antigen and its use in vaccination
05/14/1999WO1999006068A3 Recombinant dimeric envelope vaccine against flaviviral infection
05/14/1999WO1999005269A8 Transcriptional silencer protein nrf
05/14/1999WO1999002183A3 A method of inducing a ctl response
05/14/1999WO1998033904A3 An antisense oligonucleotide preparation method
05/14/1999CA2309175A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
05/14/1999CA2308852A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections
05/14/1999CA2308317A1 Novel metal complexes
05/14/1999CA2308299A1 Conjugate heat shock protein-binding peptides
05/14/1999CA2308135A1 Novel metal complexes
05/14/1999CA2307541A1 Encapsulated immunomodulators useful as vaccine adjuvants
05/14/1999CA2307219A1 Prepolymer compositions comprising an antimicrobial agent
05/12/1999EP0915162A2 Adenine phosphoribosyltransferase
05/12/1999EP0915161A2 DnaG DNA primase of Streptococcus pneumoniae
05/12/1999EP0914831A2 Biological product for preventive or therapeutic oral administration against canine parvovirosis
05/12/1999EP0914826A1 Wound healing accelerators
05/12/1999EP0914778A1 Oral administration of bacteria at a concentration which produces cell-mediated immunity and weight in certain animals
05/12/1999EP0914456A1 Gene expression in monocytes and macrophages
05/12/1999EP0914444A1 Vectors comprising sar elements
05/12/1999EP0914443A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
05/12/1999EP0914442A1 Avian polynucleotide vaccine formula
05/12/1999EP0914440A1 Nucleic acid vaccination for parvoviral infections
05/12/1999EP0914435A1 Hybrid interferon compositions and methods of use
05/12/1999EP0914432A2 Secreted proteins and polynucleotides encoding them
05/12/1999EP0914423A2 Inhibition of hiv-1 replication by antisense rna expression
05/12/1999EP0914422A1 Mammalian genes involved in viral infection and tumor suppression
05/12/1999EP0914346A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FC$g(a) RECEPTOR ANTIBODIES
05/12/1999EP0914341A1 Antagonists of intestinotrophic glp-2 peptides
05/12/1999EP0914328A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE
05/12/1999EP0914327A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE
05/12/1999EP0914325A1 Modulators of the function of fas receptors and other proteins
05/12/1999EP0914153A1 Multivalent dtp-polio vaccines
05/12/1999EP0914144A1 Therapeutic uses of bpi protein products for human meningococcemia
05/12/1999EP0914142A1 Peptides with increased binding affinity for hla molecules
05/12/1999EP0914139A2 Antiviral agents from plant extracts and use for treatment of viral infections
05/12/1999EP0914130A2 Novel anti-viral compounds
05/12/1999EP0914127A2 Antifungal composition with enhanced bioavailability
05/12/1999EP0914125A1 Hiv protease inhibitors useful for the treatment of aids
05/12/1999EP0914115A1 Methods of providing neuroprotection
05/12/1999EP0914102A1 Compositions and methods for treating or preventing diseases of body passageways
05/12/1999EP0914100A1 Oral composition comprising a triazole antifungal compound
05/12/1999EP0914091A2 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
05/12/1999EP0914040A1 Antimicrobial composition and methods of use therefor
05/12/1999EP0733067B1 N-terminally chemically modified protein compositions and methods
05/12/1999EP0654037B1 Antiretroviral enantiomeric nucleotide analogs
05/12/1999CN1216549A Antipathogenic peptides and compositions comprising them
05/12/1999CN1216539A Antivirally active heterocyclic azahexane derivatives
05/12/1999CN1216470A DHEA combination therapy
05/12/1999CN1216246A Antimicrobial composition
05/12/1999CN1043347C 2-heteroaryl-5,11-dihydro-6H-dipyrido [3,2-b: 2',3'-3]-3] [1,4] diazepines and their use in the prevention or treatment of HIV infection
05/11/1999US5902810 Pteridine derivatives as no synthase inhibitors
05/11/1999US5902803 5H,10H-imidazo 1,2-a!indeno 1,2-e!pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives
05/11/1999US5902796 Bioactive factors of aloe vera plants
05/11/1999US5902586 Meningococcal polysaccharide conjugate vaccine
05/11/1999CA2141871C Novel attenuated pseudomonas aeruginosa strains
05/11/1999CA2061177C Bacteriocin from lactococcus lactis subspecies lactis
05/07/1999CA2253064A1 Nef action inhibitor
05/06/1999WO1999021871A1 2-halo-6-o-substituted ketolide derivatives
05/06/1999WO1999021870A1 Erythromycin a 11, 12-carbamate derivatives
05/06/1999WO1999021869A1 Erythromycin a, 11,12-carbamate derivatives
05/06/1999WO1999021864A1 6,11-bridged erythromycin derivatives
1 ... 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 ... 1798